I love to repurpose items, reduce waste, and conserve resources as much as possible, and there are many opportunities to do ...

While Jessica Blehm is now available to treat a wide range of conditions at The Center for Counseling & Consultation, she is ...

Six months after treatment with the radiopharmaceutical therapy, 77.8% of patients with meningioma were alive and had not ...

According to DelveInsight’s analysis, the growth of the KRAS Inhibitors market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, and robust pipeline ...

The European Commission approved Johnson and Johnson’s Yuvanci as the first single-pill combination therapy for PAH.

Langston University and Arkansas Colleges of Health Education (ACHE) signed an education affiliation agreement on Thursday to ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

FDA confirms that SciSparc's study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc") ...

In recent years, stem cell therapy has gained widespread attention for its incredible ability to regenerate damaged cells and ...

Clyde Yancy, MD, MSc, FHFSA, professor, chief of cardiology, and vice dean of diversity and inclusion at Northwestern ...

Prime Medicine will partner with Bristol Myers Squibb (BMS) to develop and commercialize an unspecified number of reagents for ex vivo T-cell therapies through a collaboration that could generate more ...

Medications and therapy are two of the most common treatments for anxiety, and they're highly effective. But there are also ...